Everest will continue to develop self-discovered products utilizing the mRNA platform Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of...
Study conducted by Meiji Seika Pharma in Japan Data follow approval of the world’s first self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine for adults by Japan Ministry of Health, Labor and Welfare The randomized, double-blind, active-controlled study,...
In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer. People with advanced melanomas who received the vaccine plus Merck’s cancer drug...
Skip Therapeutics (“Skip”), developer of computational platform for design of Antisense Oligonucleotide (ASO) based therapies and Sheba Medical Center (“Sheba”), one of the leading medical centers in the world, announced today that they have...
Nonprofit standards organization, U.S. Pharmacopeia (USP), has given a talk as part of efforts to raise awareness of its standards for biologics including mAbs and vaccines. USP, which aims to build trust in medicines through public quality standards, says that many...